These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 9666526
1. The effect of naftidrofuryl on transcutaneous oxygen tension during a treadmill test in patients with peripheral arterial occlusive disease. Mouren X, Caillard P, Bensoussan JJ, Massonneau M, Gamand S, Stevens WH. Vasc Med; 1998; 3(1):9-14. PubMed ID: 9666526 [Abstract] [Full Text] [Related]
3. Transcutaneous oxygen tension and Doppler ankle pressure during upper and lower body exercise in patients with peripheral arterial occlusive disease. Liu Y, Steinacker JM, Stauch M. Angiology; 1995 Aug; 46(8):689-98. PubMed ID: 7639415 [Abstract] [Full Text] [Related]
4. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination. Mouren X, Caillard P, Schwartz F. Angiology; 1994 Jun; 45(6):413-7. PubMed ID: 8203766 [Abstract] [Full Text] [Related]
7. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study. Adhoute G, Andreassian B, Boccalon H, Cloarec M, Di Maria G, Lefebvre O, Mondine P, Plagnol P, Pointel JP, Quancard X. J Cardiovasc Pharmacol; 1990 Jun; 16 Suppl 3():S75-80. PubMed ID: 1369725 [Abstract] [Full Text] [Related]
10. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies. Pointel JP, Thomas C, Mosnier M, Percebois G, Debry G. Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072 [Abstract] [Full Text] [Related]
11. Prevalence and Causes of Normal Exercise Oximetry in the Calf in Patients with Peripheral Artery Disease and Limiting Calf Claudication. Signolet I, Henni S, Colas-Ribas C, Feuilloy M, Picquet J, Abraham P. Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):572-8. PubMed ID: 26905471 [Abstract] [Full Text] [Related]
12. Naftidrofuryl in quality of life (NIQOL). A Belgian study. D'Hooge D, Lehert P, Clement DL. Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694 [Abstract] [Full Text] [Related]
13. Naftidrofuryl: a review of its use in the treatment of intermittent claudication. Goldsmith DR, Wellington K. Drugs Aging; 2005 Dec; 22(11):967-77. PubMed ID: 16323973 [Abstract] [Full Text] [Related]
14. [Effect of naftidrofuryl on physiological walking distance in patients with intermittent claudication]. Boccalon H, Lehert P, Mosnier M. Ann Cardiol Angeiol (Paris); 2001 Apr; 50(3):175-82. PubMed ID: 12555510 [Abstract] [Full Text] [Related]
16. Assessment of flow and oxygen delivery to the lower extremity in arterial insufficiency: a PET-scan study comparison with other methods. Depairon M, Depresseux JC, Petermans J, Zicot M. Angiology; 1991 Oct; 42(10):788-95. PubMed ID: 1952268 [Abstract] [Full Text] [Related]
20. Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease. Liu Y, Opitz-Gress A, Rott A, Liewald F, Sunder-Plassmann L, Lehmann M, Stauch M, Steinacker JM. Vasc Med; 1997 Oct; 2(1):13-8. PubMed ID: 9546944 [Abstract] [Full Text] [Related] Page: [Next] [New Search]